Newstral
Article
bizjournals.com on 2017-10-06 13:38
Diabetes community concerned about J&J's decision to stop making insulin pumps
Related news
- Video: Cyber bug in J&J's insulin pumpThe Globe and Mail
- FJ&J warns insulin pumps could be hackedft.com
- J&J Abandoning Insulin Pumpswsj.com
- J&J's 2014 revenue rose, profits soaredPhilly.com
- J&J's single-shot vaccine 66% effectivereuters.com
- Patent for J&J's Remicade invalidatedThe Salt Lake Tribune
- EU regulator recommends using J&J's one-shot vaccinelasvegassun.com
- J&J's booster shown effective against Covid hospitalizationPOLITICO
- J&J's deceptive marketing fuelled US opioid crisis, court hearsSydney Morning Herald
- What To Make Of J&J's First Xarelto Lawsuit LossForbes
- EU considers booster doses of J&J's COVID-19 vaccinedailyherald.com
- J&J's single-dose Covid vax gets emergency use nodThe Times of India
- CDC panel recommends Pfizer, Moderna COVID shots over J&J'slasvegassun.com
- U.S. calls for pause on J&J's COVID-19 vaccinereuters.com
- VJ&J's one-dose vaccine offers hope in virus fightvideo.startribune.com
- J&J bows to Medtronic, will exit insulin-pump marketbizjournals.com
- MJ&J warns insulin pump vulnerable to cyber hackingmarketwatch.com
- J&J, ViaCyte testing possible diabetes cureThe Salt Lake Tribune
- Cardinal Health to Buy J&J's Heart Business for $1.94 Billionwsj.com